We are live on ! Find out more
FCMV

Foresite Capital Management V Portfolio holdings

AUM $271M
1-Year Est. Return 309.87%
This Fund
S&P 500
This Quarter Est. Return
+35.36%
1 Year Est. Return
+309.87%
3 Year Est. Return
+356.88%
5 Year Est. Return
+250.56%
10 Year Est. Return
–
AUM
$340M
AUM Growth
+$205M
Cap. Flow
+$224M
Cap. Flow %
65.83%
Top 10 Hldgs %
88.03%
Holding
21
New
9
Increased
1
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
CGEM icon
Cullinan Oncology
CGEM
+$111M
2
IRON icon
Disc Medicine
IRON
+$36.2M
3
ACRS icon
Aclaris Therapeutics
ACRS
+$24.6M
4
PHVS icon
Pharvaris
PHVS
+$20.9M
5
LHDX
Lucira Health, Inc. Common Stock
LHDX
+$9.62M

Top Sells

Rank Stock Value
1
ABCL icon
AbCellera Biologics
ABCL
+$805K

Sector Composition

Rank Sector Weight
1 Healthcare 95.37%
2 Financials 1.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGEM icon
1
Cullinan Oncology
CGEM
$1.08B
$114M 33.46%
+2,731,410
New +$111M
IRON icon
2
Disc Medicine
IRON
$3.03B
$33M 9.7%
+81,171
New +$36.2M
ACRS icon
3
Aclaris Therapeutics
ACRS
$743M
$31.7M 9.32%
+1,258,243
New +$24.6M
KNTE
4
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$27.3M 8.02%
875,001
– –
ALXO icon
5
ALX Oncology
ALXO
$262M
$23.6M 6.94%
320,000
– –
PHVS icon
6
Pharvaris
PHVS
$2.37B
$18.6M 5.46%
+664,142
New +$20.9M
NRIX icon
7
Nurix Therapeutics
NRIX
$2.45B
$14M 4.13%
451,522
– –
HIMS icon
8
Hims & Hers Health
HIMS
$6.26B
$14M 4.11%
1,056,922
+185,500
+21% +$3.11M
RLAY icon
9
Relay Therapeutics
RLAY
$4.24B
$13.8M 4.07%
400,000
– –
PHICU
10
DELISTED
Population Health Investment Co., Inc. Unit
PHICU
$9.65M 2.84%
960,000
– –
OLK
11
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$7.2M 2.12%
+200,000
New +$6.74M
PRDS
12
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$6M 1.76%
+602,500
New +$6.23M
LHDX
13
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$5.87M 1.73%
+485,000
New +$9.62M
RACB
14
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$5.13M 1.51%
+500,000
New +$5.12M
TNGX icon
15
Tango Therapeutics
TNGX
$4.49B
$4.45M 1.31%
400,000
– –
SNCE
16
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$4.06M 1.19%
20,000
– –
PNT
17
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$3.68M 1.08%
350,000
– –
MLTX icon
18
MoonLake Immunotherapeutics
MLTX
$1.62B
$2.55M 0.75%
250,000
– –
IMVT icon
19
Immunovant
IMVT
$8.11B
$802K 0.24%
+50,000
New +$1.32M
ABCL icon
20
AbCellera Biologics
ABCL
$1.74B
– –
-20,000
Closed -$805K

Similar funds

MAM
Mullooly Asset Management Wall Township, New Jersey $271M AUM 16.93% 1-Year Est. Return
MLM
Mount Lucas Management Newtown, Pennsylvania $271M AUM 25.49% 1-Year Est. Return
MCM
Moerus Capital Management New York $271M AUM 58.78% 1-Year Est. Return
RP
Ravenswood Partners Mclean, Virginia $271M AUM
PCM
Punch Card Management Winter Park, Florida $271M AUM 11.49% 1-Year Est. Return
S
Siemens Munich, Germany $272M AUM 183.71% 1-Year Est. Return
VW
Veridan Wealth West Linn, Oregon $270M AUM
TP
TritonPoint Partners Chevy Chase, Maryland $272M AUM

Foresite Capital Management V's Q1 2021 Portfolio in Review

As of Q1 2021, Foresite Capital Management V held 21 positions worth $340M, up 152% from $135M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Foresite Capital Management V deployed $224M of net new capital in Q1 2021, opening 9 new positions and adding to 1 existing holding. Its largest new stake was Cullinan Oncology: 2,731,410 shares worth $114M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 92% a quarter earlier, followed by Financials.

On the sell side, the most notable exit was AbCellera Biologics, an estimated $805K sold.

  • Foresite Capital Management V's largest Q1 2021 buy was Cullinan Oncology: 2,731,410 shares worth $114M.
  • Foresite Capital Management V added most to Hims & Hers Health in Q1 2021, an estimated $3.11M increase.
  • Foresite Capital Management V fully exited AbCellera Biologics in Q1 2021, selling an estimated $805K.
  • Foresite Capital Management V's ten largest holdings make up 88% of its $340M portfolio in Q1 2021.
  • Foresite Capital Management V opened 9 new positions and closed 1 in Q1 2021.
  • Foresite Capital Management V's portfolio value rose 152% quarter-over-quarter to $340M.

Based on Foresite Capital Management V's 13F filing for Q1 2021, filed 17 May 2021.